D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Parsons
PSN
$8.15B
| $1.27M | ﹤0.01% |
+34,437
| New | +$1.27M |
|
1752
Transocean
RIG
$3.09B
| $1.26M | ﹤0.01% |
197,161
+71,767
| +57% | +$460K |
|
1753
ANI Pharmaceuticals
ANIP
$2.14B
| $1.26M | ﹤0.01% |
15,357
+8,255
| +116% | +$678K |
|
1754
Cyclerion Therapeutics
CYCN
$7.88M
| $1.26M | ﹤0.01% |
+5,482
| New | +$1.26M |
|
1755
Emerald Holding
EEX
$996M
| $1.25M | ﹤0.01% |
111,902
+912
| +0.8% | +$10.2K |
|
1756
Ventas
VTR
$31.6B
| $1.25M | ﹤0.01% |
18,225
-288
| -2% | -$19.7K |
|
|
TCO
1757
DELISTED
Taubman Centers Inc.
TCO
| $1.25M | ﹤0.01% |
+30,482
| New | +$1.25M |
|
1758
Albany International
AIN
$1.74B
| $1.24M | ﹤0.01% |
14,939
-12,494
| -46% | -$1.04M |
|
1759
Agree Realty
ADC
$8.12B
| $1.24M | ﹤0.01% |
19,315
-10,401
| -35% | -$666K |
|
1760
Mizuho Financial
MFG
$82B
| $1.23M | ﹤0.01% |
428,380
+162,606
| +61% | +$468K |
|
1761
Novo Nordisk
NVO
$243B
| $1.23M | ﹤0.01% |
48,178
-68,958
| -59% | -$1.76M |
|
1762
Community Bank
CBU
$3.1B
| $1.23M | ﹤0.01% |
18,604
-2,197
| -11% | -$145K |
|
1763
The RMR Group
RMR
$287M
| $1.22M | ﹤0.01% |
26,006
+21,138
| +434% | +$993K |
|
1764
Core Laboratories
CLB
$592M
| $1.22M | ﹤0.01% |
23,342
+10,718
| +85% | +$560K |
|
|
ARNA
1765
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.22M | ﹤0.01% |
+20,788
| New | +$1.22M |
|
1766
Customers Bancorp
CUBI
$2.31B
| $1.21M | ﹤0.01% |
57,765
-77,353
| -57% | -$1.62M |
|
1767
SLR Investment Corp
SLRC
$884M
| $1.2M | ﹤0.01% |
58,501
-3,144
| -5% | -$64.5K |
|
|
LION
1768
DELISTED
Fidelity Southern Corporation
LION
| $1.2M | ﹤0.01% |
38,676
-17,464
| -31% | -$541K |
|
1769
PNC Financial Services
PNC
$79.6B
| $1.2M | ﹤0.01% |
8,721
+941
| +12% | +$129K |
|
|
PNNT
1770
Pennant Park Investment Corp
PNNT
$466M
| $1.19M | ﹤0.01% |
187,968
+8,747
| +5% | +$55.3K |
|
1771
Eldorado Gold
EGO
$5.69B
| $1.19M | ﹤0.01% |
204,167
-885,096
| -81% | -$5.15M |
|
1772
Hershey
HSY
$37.3B
| $1.19M | ﹤0.01% |
+8,851
| New | +$1.19M |
|
|
HOLI
1773
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $1.19M | ﹤0.01% |
62,430
-87,662
| -58% | -$1.67M |
|
1774
Ovintiv
OVV
$10.9B
| $1.18M | ﹤0.01% |
46,163
-87,442
| -65% | -$2.24M |
|
|
WLH
1775
DELISTED
WILLIAM LYON HOMES
WLH
| $1.18M | ﹤0.01% |
64,941
+27,014
| +71% | +$493K |
|